concept

TAU AGGREGATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

78Connections

2Hypotheses

15Analyses

20Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	TAU AGGREGATION

Pathway Diagram

graph TD
    TAU_AGGREGATION["TAU AGGREGATION"]
    TAU_AGGREGATION -->|"causes"| Alzheimer_s_Disease["Alzheimer's Disease"]
    TAU_AGGREGATION -->|"causes"| Tauopathies["Tauopathies"]
    TAU_AGGREGATION -->|"contributes to"| Neurodegeneration["Neurodegeneration"]
    MAPT["MAPT"] -->|"involved_in"| TAU_AGGREGATION
    TRIM11["TRIM11"] -->|"inhibits"| TAU_AGGREGATION
    TAU["TAU"] -->|"implicated in"| TAU_AGGREGATION
    Misfolded_Tau["Misfolded Tau"] -->|"causes"| TAU_AGGREGATION
    Neddylation_Inhibition["Neddylation Inhibition"] -->|"upregulates"| TAU_AGGREGATION
    AQP4["AQP4"] -.protects against.-> TAU_AGGREGATION
    Impaired_Glymphatic_Clearance["Impaired Glymphatic Clearance"] -->|"contributes to"| TAU_AGGREGATION
    BMAL1["BMAL1"] -->|"regulates"| TAU_AGGREGATION

Outgoing (20)

Target	Relation	Type	Str
Alzheimer's Disease	causes	disease	0.95
Tauopathies	causes	disease	0.95
Alzheimer's Disease	contributes_to	disease	0.95
Neurodegeneration	causes	disease	0.95
neurodegeneration	mediates	process	0.93
Alzheimer's Disease	biomarker_for	disease	0.92
neuronal dysfunction	promotes	phenotype	0.92
Alzheimer's Disease	associated_with	disease	0.90
Frontotemporal Dementia	associated_with	disease	0.90
tau seeds	propagates	protein_aggregate	0.90
cognitive decline	drives	phenotype	0.88
Neurodegeneration	contributes_to	process	0.88
cellular senescence	causes (tau aggregation triggers cellular senescence respo)	mechanism	0.70
tau propagation	promotes	process	0.70
Alzheimer's_disease	causes	disease	0.70
neurodegeneration	causes	disease	0.70
pH acidification	causes	phenotype	0.70
membrane asymmetry disruption	causes	phenotype	0.70
neurodegeneration	causes	disease	0.70
pH_acidification	causes	gene	0.70

Incoming (58)

Source	Relation	Type	Str
TRIM11	inhibits	protein	0.95
AMYLOID-BETA	associated_with	protein	0.95
MAPT	involved_in	protein	0.95
TAU	implicated_in	entity	0.92
BMAL1	promotes	gene	0.90
Caspase-3 cleavage at D421	causes	process	0.90
AQP4	protects_against	gene	0.90
Impaired Glymphatic Clearance	contributes_to	process	0.90
BMAL1	regulates	gene	0.90
36563857	prevented	paper	0.90
41478829	reduces	paper	0.90
Neddylation Inhibition	upregulates	mechanism	0.90
28678775	defines the seed for	paper	0.90
Misfolded Tau	causes	protein	0.90
prion-like templating	activates	phenotype	0.90
autophagy	prevents	pathway	0.90
TAU	involved_in	protein	0.90
TAU	propagates	protein	0.90
CDK5	mediates	protein	0.90
BMAL1	inhibits	gene	0.85
Protopanaxatriol	inhibits	compound	0.85
Tau Phosphorylation	associated_with	process	0.85
Heparin	associated_with	drug	0.85
Tau Hyperphosphorylation	contributes_to	process	0.85
Tau Mutations	contributes_to	mechanism	0.85
Tau mRNA Splicing Disruption	contributes_to	process	0.85
Tau Post-Translational Modifications	contributes_to	process	0.85
Prion-like Propagation	mediates	mechanism	0.85
Oxidative Stress	contributes_to	process	0.80
Inflammation	contributes_to	process	0.80
GPCR dysregulation	promotes	phenotype	0.80
O-GlcNAcylation Thr231	inhibits	protein	0.70
AQP4 inhibition	promotes	process	0.70
p62	regulates	protein	0.70
K280 acetylation	causes	protein_modification	0.70
Cis-pS199 Tau conformer	causes	protein	0.70
anti_soluble_tau_oligomer_antibodies	inhibits	drug	0.70
O-GlcNAcylation	inhibits	process	0.70
HDAC6	regulates	gene	0.70
autophagy	protects_against	process	0.70
phosphatidylserine exposure	associated_with	phenotype	0.70
Amyloid-β	activates	protein	0.70
CASP2	causes	gene	0.70
TFEB overexpression	inhibits	phenotype	0.70
CASP3	causes	gene	0.70
Tau protein	activates	protein	0.70
AADvac1	targets	drug	0.70
tau acetylation at K280	causes	process	0.70
D421 tau fragment	causes	protein	0.70
cellular senescence	causes (senescence creates a self-perpetuating cycle by pr)	mechanism	0.70

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Direct cystatin C inhibition of tau aggregation	0.390	neurodegeneration	Does the cancer-cystatin-C-TREM2 pathway
PS Externalization Requires Tau Aggregation-Phase Transition	0.000	-	Does tau aggregation specifically cause

Mentioning Analyses (15)

Scientific analyses that reference this entity

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

proteomics | 2026-04-16 | 19 hypotheses Top: 0.591

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.634

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

What is the atomic-resolution structure of K280-acetylated tau and how does it t

structural biology | 2026-04-13 | 1 hypotheses Top: 0.643

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

The core research question was never addressed due to missing literature content

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The debate was structured around this question but no literature was provided to

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The debate identified glycolytic shifts and mTOR disruption but couldn't disting

closed · Rounds: 4 · Score: 0.48 · 2026-04-21

The debate highlighted fundamental disagreement about tau's role - whether aggre

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

How does synaptic protein turnover change with age and neurodegeneration, and wh

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

closed · Rounds: 4 · Score: 0.92 · 2026-04-16

The abstract challenges the rationale for using microtubule-stabilizing drugs in

closed · Rounds: 4 · Score: 0.68 · 2026-04-15

The debate highlighted tau prion-like transmission but did not resolve how diffe

closed · Rounds: 4 · Score: 0.57 · 2026-04-15

The debate proposed K280 acetylation creates a β-sheet nucleation interface but

closed · Rounds: 4 · Score: 0.86 · 2026-04-14

The debate proposed K280 acetylation creates a β-sheet nucleation interface but

closed · Rounds: 4 · Score: 0.74 · 2026-04-14

Related Research

Hypotheses and analyses mentioning TAU AGGREGATION in their description or question text

No additional research found

TAU AGGREGATION

Understanding Entity Pages

Pathway Diagram

Outgoing (20)

Incoming (58)

Targeting Hypotheses (2)

Mentioning Analyses (15)

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

What are the specific molecular determinants that govern tau strain selection du

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

What is the atomic-resolution structure of K280-acetylated tau and how does it t

Do tau aggregates represent protective responses or primary pathogenic drivers i

Which specific metabolic pathways in APOE4 microglia are causally linked to dysf

Which specific post-translational modifications create druggable epitopes unique

Which specific post-translational modifications distinguish pathological from ph

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

Which specific post-translational modifications on pathological tau create drugg

Tau propagation mechanisms and therapeutic interception points

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

4R-tau strain-specific spreading patterns in PSP vs CBD

4R-tau strain-specific spreading patterns in PSP vs CBD

Experiments (0)

Related Papers (0)

Debates (20)

The core research question was never addressed due to missing literature content

The debate was structured around this question but no literature was provided to

The debate identified glycolytic shifts and mTOR disruption but couldn't disting

The debate highlighted fundamental disagreement about tau's role - whether aggre

How does synaptic protein turnover change with age and neurodegeneration, and wh

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

The abstract challenges the rationale for using microtubule-stabilizing drugs in

The debate highlighted tau prion-like transmission but did not resolve how diffe

The debate proposed K280 acetylation creates a β-sheet nucleation interface but

The debate proposed K280 acetylation creates a β-sheet nucleation interface but

Related Research